Atopic wheezing and early life antibiotic exposure: a nested case-control study

Michael David Thomas, A Custovic, A Woodcock, J. Simpson, A. Murray

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Several factors including early-life antibiotic usage have been implicated in the rising prevalence of allergic sensitization and asthma. A nested case-control study comparing antibiotic exposure of 37 sensitized children with recurrent wheeze (age 3-5 yr) and 37 non-sensitized children who had never wheezed was carried out within a population-based birth cohort (matching for age, sex, parental atopy, allergen exposure, and pet ownership). We collected data on antibiotic prescriptions during first 3 yr of life (timing, type, indication) from the primary care medical records. Significantly, more cases than controls received one or more antibiotic courses during the first year of life (92% vs. 70%, p = 0.04). The median time to first antibiotic course was shorter for the cases than the controls (6 vs. 8 months, p = 0.03). The total number of antibiotic receipts was greater amongst cases in each of the first 3 yr of life, but this reached significance only when the whole three-year period was considered (249 vs. 182 courses, p = 0.05). The increased ratio of antibiotic receipt in cases over controls was highest in the first year of life (1.32, 95% CI 0.99-1.78). Significantly more cases than controls were prescribed antibiotics for lower respiratory tract infection during the first 3 yr (p = 0.007), but not during the first year of life (p = 0.52). Antibiotics use by class was similar in the two groups. Our data support the hypothesis that early life exposure to broad-spectrum antibiotics may have a causative role in sensitisation and the expression of wheeze.

Original languageEnglish
Pages (from-to)184-188
Number of pages5
JournalPediatric Allergy & Immunology
Volume17
DOIs
Publication statusPublished - 1 Jan 2006

Keywords

  • wheeze
  • allergic sensitization
  • antibiotics
  • children
  • early-childhood
  • allergic disease
  • asthma
  • infections
  • cohort
  • Risk
  • 1ST

Cite this

Atopic wheezing and early life antibiotic exposure : a nested case-control study. / Thomas, Michael David; Custovic, A; Woodcock, A; Simpson, J.; Murray, A.

In: Pediatric Allergy & Immunology, Vol. 17, 01.01.2006, p. 184-188.

Research output: Contribution to journalArticle

Thomas, Michael David ; Custovic, A ; Woodcock, A ; Simpson, J. ; Murray, A. / Atopic wheezing and early life antibiotic exposure : a nested case-control study. In: Pediatric Allergy & Immunology. 2006 ; Vol. 17. pp. 184-188.
@article{1e361379de1141c7a7d2a0d92a8da5a6,
title = "Atopic wheezing and early life antibiotic exposure: a nested case-control study",
abstract = "Several factors including early-life antibiotic usage have been implicated in the rising prevalence of allergic sensitization and asthma. A nested case-control study comparing antibiotic exposure of 37 sensitized children with recurrent wheeze (age 3-5 yr) and 37 non-sensitized children who had never wheezed was carried out within a population-based birth cohort (matching for age, sex, parental atopy, allergen exposure, and pet ownership). We collected data on antibiotic prescriptions during first 3 yr of life (timing, type, indication) from the primary care medical records. Significantly, more cases than controls received one or more antibiotic courses during the first year of life (92{\%} vs. 70{\%}, p = 0.04). The median time to first antibiotic course was shorter for the cases than the controls (6 vs. 8 months, p = 0.03). The total number of antibiotic receipts was greater amongst cases in each of the first 3 yr of life, but this reached significance only when the whole three-year period was considered (249 vs. 182 courses, p = 0.05). The increased ratio of antibiotic receipt in cases over controls was highest in the first year of life (1.32, 95{\%} CI 0.99-1.78). Significantly more cases than controls were prescribed antibiotics for lower respiratory tract infection during the first 3 yr (p = 0.007), but not during the first year of life (p = 0.52). Antibiotics use by class was similar in the two groups. Our data support the hypothesis that early life exposure to broad-spectrum antibiotics may have a causative role in sensitisation and the expression of wheeze.",
keywords = "wheeze, allergic sensitization, antibiotics, children, early-childhood, allergic disease, asthma , infections, cohort, Risk, 1ST",
author = "Thomas, {Michael David} and A Custovic and A Woodcock and J. Simpson and A. Murray",
year = "2006",
month = "1",
day = "1",
doi = "10.1111/j.1399-3038.2006.00389.x",
language = "English",
volume = "17",
pages = "184--188",
journal = "Pediatric Allergy & Immunology",
issn = "0905-6157",
publisher = "Blackwell Munksgaard",

}

TY - JOUR

T1 - Atopic wheezing and early life antibiotic exposure

T2 - a nested case-control study

AU - Thomas, Michael David

AU - Custovic, A

AU - Woodcock, A

AU - Simpson, J.

AU - Murray, A.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Several factors including early-life antibiotic usage have been implicated in the rising prevalence of allergic sensitization and asthma. A nested case-control study comparing antibiotic exposure of 37 sensitized children with recurrent wheeze (age 3-5 yr) and 37 non-sensitized children who had never wheezed was carried out within a population-based birth cohort (matching for age, sex, parental atopy, allergen exposure, and pet ownership). We collected data on antibiotic prescriptions during first 3 yr of life (timing, type, indication) from the primary care medical records. Significantly, more cases than controls received one or more antibiotic courses during the first year of life (92% vs. 70%, p = 0.04). The median time to first antibiotic course was shorter for the cases than the controls (6 vs. 8 months, p = 0.03). The total number of antibiotic receipts was greater amongst cases in each of the first 3 yr of life, but this reached significance only when the whole three-year period was considered (249 vs. 182 courses, p = 0.05). The increased ratio of antibiotic receipt in cases over controls was highest in the first year of life (1.32, 95% CI 0.99-1.78). Significantly more cases than controls were prescribed antibiotics for lower respiratory tract infection during the first 3 yr (p = 0.007), but not during the first year of life (p = 0.52). Antibiotics use by class was similar in the two groups. Our data support the hypothesis that early life exposure to broad-spectrum antibiotics may have a causative role in sensitisation and the expression of wheeze.

AB - Several factors including early-life antibiotic usage have been implicated in the rising prevalence of allergic sensitization and asthma. A nested case-control study comparing antibiotic exposure of 37 sensitized children with recurrent wheeze (age 3-5 yr) and 37 non-sensitized children who had never wheezed was carried out within a population-based birth cohort (matching for age, sex, parental atopy, allergen exposure, and pet ownership). We collected data on antibiotic prescriptions during first 3 yr of life (timing, type, indication) from the primary care medical records. Significantly, more cases than controls received one or more antibiotic courses during the first year of life (92% vs. 70%, p = 0.04). The median time to first antibiotic course was shorter for the cases than the controls (6 vs. 8 months, p = 0.03). The total number of antibiotic receipts was greater amongst cases in each of the first 3 yr of life, but this reached significance only when the whole three-year period was considered (249 vs. 182 courses, p = 0.05). The increased ratio of antibiotic receipt in cases over controls was highest in the first year of life (1.32, 95% CI 0.99-1.78). Significantly more cases than controls were prescribed antibiotics for lower respiratory tract infection during the first 3 yr (p = 0.007), but not during the first year of life (p = 0.52). Antibiotics use by class was similar in the two groups. Our data support the hypothesis that early life exposure to broad-spectrum antibiotics may have a causative role in sensitisation and the expression of wheeze.

KW - wheeze

KW - allergic sensitization

KW - antibiotics

KW - children

KW - early-childhood

KW - allergic disease

KW - asthma

KW - infections

KW - cohort

KW - Risk

KW - 1ST

U2 - 10.1111/j.1399-3038.2006.00389.x

DO - 10.1111/j.1399-3038.2006.00389.x

M3 - Article

VL - 17

SP - 184

EP - 188

JO - Pediatric Allergy & Immunology

JF - Pediatric Allergy & Immunology

SN - 0905-6157

ER -